In a letter to FDA Commissioner Dr. Martin Makary, Sen. Dick Durbin, D-Ill., questioned the “FDA’s operational capacity to carry out its mission to regulate direct-to-consumer (DTC) advertisements for prescription drugs.” Durbin, who is the Senate’s Democratic Whip, noted “four top leaders in the FDA’s OPDP have departed, including under Reduction in Force notices, including ... Read More